Showing results (651-660 of 722) with videos related to
Sort By:
Pageof 73
Circulation. Cardiovascular Interventions|October 9, 2015
Final 3-Year Outcome of a Randomized Trial Comparing Second-Generation Drug-Eluting Stents Using Either Biodegradable Polymer or Durable Polymer: NOBORI Biolimus-Eluting Versus XIENCE/PROMUS Everolimus-Eluting Stent TrialMasahiro Natsuaki, Ken Kozuma, Takeshi Morimoto, et al.Cardiovascular Intervention and Therapeutics|November 1, 2015
One-year outcome of a prospective trial stopping dual antiplatelet therapy at 3 months after everolimus-eluting cobalt-chromium stent implantation: ShortT and OPtimal duration of Dual AntiPlatelet Therapy after everolimus-eluting cobalt-chromium stent (STOPDAPT) trialMasahiro Natsuaki, Takeshi Morimoto, Erika Yamamoto, et al.Scientific Reports|November 2, 2013
Increased tissue levels of omega-3 polyunsaturated fatty acids prevents pathological preterm birthAki Yamashita, Kei Kawana, Kensuke Tomio, et al.International Journal of Cardiology|March 21, 2025
Cumulative plaque burden analysis for phenotyping epicardial coronary artery diseaseTsung-Ying Tsai, Pruthvi C Revaiah, Ali Aldujeli, et al.Cells|July 26, 2024
Identification of Genomic Predictors of Muscle Fiber SizeJoão Paulo L F Guilherme, Ekaterina A Semenova, Naoki Kikuchi, et al.Circulation Journal : Official Journal of the Japanese Circulation Society|November 6, 2024
Phase 3 Open-Label Study Evaluating the Efficacy and Safety of Mavacamten in Japanese Adults With Obstructive Hypertrophic Cardiomyopathy - The HORIZON-HCM StudyHiroaki Kitaoka, Masaki Ieda, Mio Ebato, et al.Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|October 10, 2020
Comparative influence of bleeding and ischemic risk factors on diabetic patients undergoing percutaneous coronary intervention with everolimus-eluting stentsRidhima Goel, Davide Cao, Rishi Chandiramani, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|July 3, 2023
Biodegradable or durable polymer drug-eluting stents in patients with coronary artery disease: ten-year outcomes of the randomised NEXT TrialMasahiro Natsuaki, Hirotoshi Watanabe, Takeshi Morimoto, et al.Journal of Thrombosis and Thrombolysis|March 12, 2021
Impact of renal function in high bleeding risk patients undergoing percutaneous coronary intervention: a patient-level stratified analysis from four post-approval studiesToshiki Kuno, Bimmer Claessen, Davide Cao, et al.The EMBO Journal|February 14, 2009
ASK1 and ASK2 differentially regulate the counteracting roles of apoptosis and inflammation in tumorigenesisTakayuki Iriyama, Kohsuke Takeda, Hiromi Nakamura, et al.Pageof 73